Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy

BACKGROUND: VeriStrat test is a serum assay which uses a mass spectrometry (MS)-based proteomic signature derived from machine learning. It is currently used as a prognostic marker for patients with non-small cell lung cancer (NSCLC) receiving chemotherapy. However, little is known about its role fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Chae, Young Kwang, Kim, Won Bin, Davis, Andrew A., Park, Lee Chun, Anker, Jonathan F., Simon, Nicholas I., Rhee, Kyunghoon, Song, Junho, Cho, Anderson, Chang, Sangmin, Ko, Taeyeong, Oh, Michael, Bhave, Manali, Viveiros, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481587/
https://ncbi.nlm.nih.gov/pubmed/32953481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados